摘要
目的分析雷贝拉唑、莫沙必利和铝镁加联合治疗反流性食管炎的临床疗效。方法选取2014年4月~2015年1月我院收治的76例反流性食管炎患者为研究对象,将其随机分为观察组与对照组,观察组给予雷贝拉唑、莫沙必利联合铝镁加治疗,对照组给予雷贝拉唑、莫沙必利治疗,比较两组患者的临床疗效。结果观察组总有效率高于对照组（P〈0.05）;两组患者不良反应发生率比较,无统计学意义（P〉0.05）。结论雷贝拉唑、莫沙必利和铝镁加联合治疗反流性食管炎的临床效果显著。
Objective To analysis the thunder Bella azole, moser will benefit and aluminum magnesium combined clinical curative effect in treatment of reflux esophagitis. Methods April 2014 ~ January 2015 of our hospital 76 cases of reflux esophagitis patients as the research object, which were randomly divided into observation group and control group, the observation group was given ray azole Bella, moser shall be the joint aluminum magnesium treatment, control group given ray, moser will treatment to compare the clinical efficacy of two groups of patients. Results The observation group total effective rate was higher than control group（P〈0.05）; Compare the incidence of adverse reactions, two groups of patients have no statistical significance（P〉0.05）. Conclusion Rabeprazole azole, moser will benefit and aluminum magnesium combined treatment of reflux esophagitis clinical effect is remarkable, is worth popularizing in clinic.
出处
《中国卫生标准管理》
2015年第18期123-125,共3页
China Health Standard Management
关键词
雷贝拉唑
莫沙必利
铝镁加
反流性食管炎
疗效
Rabeprazole
Mosapride
Aluminum magnesium
Reflux Esophagitis
Curative effect
